This 1½ day CME course is to have experts in the field of cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of diseases affecting the heart and the blood vessels.
Topics will include: Genetics/Genomics 101, pharmacogenetics, gene risk scores, genetic purgatory, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome and the other channelopathies, hypertrophic cardiomyopathy and the other cardiomyopathies, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, and the aortopathies.
Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gage outcome. A special workshop will be provided to analyze a genetic test report and to comment on the significance of genetic test results from your patients.